Showing results (201-210 of 322) with videos related to

Sort By:
Pageof 33
The Korean Journal of Internal Medicine|March 28, 2008
Epstein-Barr virus-positivity in tumor has no correlation with the clinical outcomes of patients with angioimmunoblastic T-cell lymphomaYuna Lee, Keun-Wook Lee, Jee-Hyun Kim, et al.
Japanese Journal of Clinical Oncology|June 27, 2007
Both-sided intra-atrial intracardiac metastases as the initial presentation of testicular seminomaJae-Cheol Jo, Dae Ho Lee, Byung Wook Kang, et al.
European Journal of Haematology|February 18, 2015
TCL1 expression predicts overall survival in patients with mantle cell lymphomaSu-Jin Shin, Jin Roh, Hee Jeong Cha, et al.
Anticancer Research|May 18, 2012
The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2Dok Hyun Yoon, Jae-Sik Shin, Dong-Hoon Jin, et al.
Scientific Reports|February 4, 2021
Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders-diffuse large B-cell lymphomaJwa Hoon Kim, Hyungwoo Cho, Heungsup Sung, et al.
Annals of Hematology|August 20, 2010
Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma: a methylation-specific polymerase chain reaction study using two different primer setsGeon Park, Seong Ho Kang, Jae Hoon Lee, et al.
Leukemia & Lymphoma|October 3, 2015
Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSFJi Eun Jang, June-Won Cheong, Soo-Jeong Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group studyMotoko Yamaguchi, Yok-Lam Kwong, Won Seog Kim, et al.
Journal of Korean Medical Science|December 17, 2003
The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapyGyeong-Won Lee, Min-Hee Ryu, Jae-Lyun Lee, et al.
Bone Marrow Transplantation|December 5, 2020
Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphomaGa-Young Song, Dok Hyun Yoon, Cheolwon Suh, et al.
Pageof 33